Impact Historical Balance Sheet
| IBO Stock | USD 0.60 0.07 10.45% |
Trend analysis of Impact BioMedical, balance sheet accounts such as Total Stockholder Equity of 25.9 M or Net Debt of 9.8 M provides information on Impact BioMedical,'s total assets, liabilities, and equity, which is the actual value of Impact BioMedical, to its prevalent stockholders. By breaking down trends over time using Impact BioMedical, balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Impact |
About Impact Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Impact BioMedical, at a specified time, usually calculated after every quarter, six months, or one year. Impact BioMedical, Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Impact BioMedical, and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Impact currently owns. An asset can also be divided into two categories, current and non-current.
Impact BioMedical, Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Impact BioMedical, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Impact BioMedical, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Impact BioMedical, balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Impact BioMedical, are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most accounts from Impact BioMedical,'s balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Impact BioMedical, current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.At this time, Impact BioMedical,'s Total Stockholder Equity is very stable compared to the past year. As of the 17th of March 2025, Accounts Payable is likely to grow to about 1 M, while Total Assets are likely to drop about 39.1 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Total Current Liabilities | 10.6M | 13.1M | 15.1M | 10.3M | Total Assets | 46.5M | 44.6M | 40.2M | 39.1M |
Impact BioMedical, balance sheet Correlations
Click cells to compare fundamentals
Impact BioMedical, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Impact BioMedical,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Impact BioMedical, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impact BioMedical, will appreciate offsetting losses from the drop in the long position's value.Moving against Impact Stock
The ability to find closely correlated positions to Impact BioMedical, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Impact BioMedical, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Impact BioMedical, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Impact BioMedical, to buy it.
The correlation of Impact BioMedical, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Impact BioMedical, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.